In type 2 diabetes (T2D) patients, serum adiponectin concentrations have been found to be significantly lower than those non-T2D participants (6), but not as high as those of type 1 diabetic (T1D) patients (7). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.